QA: ARATANA THERAPEUTICS INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509190_2019_ARATANA_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509190')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001509190, ARATANA THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 58,127,000
1 IntangibleAssetsNetIncludingGoodwill 46,945,000
2 PropertyPlantAndEquipmentNet 693,000
3 remainder_Assets 671,000
4 LiabilitiesCurrent 5,557,000
5 LiabilitiesNoncurrent 57,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 6,783,000
8 SellingGeneralAndAdministrativeExpense 28,780,000
9 ResearchAndDevelopmentExpense 7,355,000
10 remainder_Expenses 4,382,000
11 remainder_Revenues 35,412,000
12 remainder_NetIncome -2,834,000
13 remainder_ComprehensiveNetIncome -473,000
  yvar yval
0 Assets 106,436,000
1 Liabilities 5,614,000
2 Expenses 47,300,000
3 Revenues 35,412,000
4 StockholdersEquity 100,822,000
5 NetIncome -14,722,000
6 ComprehensiveNetIncome -14,958,500
7 BaseVar 99,034,500
8 EconomicCapitalRatio 2.83

Edgar->Model Mapping

Feature Distribution

Change over Time